SciSparc Nutraceuticals

SciSparc Nutraceuticals is a health and wellness subsidiary associated with SciSparc that commercializes nutraceutical products derived from cannabinoid-related and lipid-based compounds. Its best-known product is CannAmide, an oral palmitoylethanolamide formulation licensed for sale as a supplement in Canada. The company also owns the Wellution brand and has used e-commerce distribution channels, including Amazon Marketplace in Canada, to market its products. SciSparc Ltd. has described the entity as part of its supplemental-sector activities and transferred its approximately 51% equity stake in SciSparc Nutraceuticals to NeuroThera Labs in 2025 as part of a broader asset transaction. Overall, the business appears focused on nutraceutical commercialization rather than clinical drug development.